1
AZD2811 and Durvalumab (MEDI4736) Combination Therapy in Relapsed Small Cell Lung Cancer
Condition(s):SCLC, RecurrentLast Updated:February 25, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):SCLC, RecurrentLast Updated:February 25, 2022Terminated
Condition(s):Advanced Solid TumoursLast Updated:May 1, 2020Completed
Condition(s):Small Cell Lung CancerLast Updated:November 27, 2018Terminated
Condition(s):Small-Cell Lung CancerLast Updated:December 15, 2022Active, not recruiting
Condition(s):Acute Myeloid LeukaemiaLast Updated:April 5, 2022Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.